Basic info
Industry
pharmaceutical manufacturing
Sectors
Pulmonology
Nephrology
Kidney Disease
Oncology
Rare Diseases
CLDN1
Claudin-1
Drug Discovery
Liver Fibrosis
ALE.F02
Lung Fibrosis
ALE.C04
Fibrotic Cancer
Hepatology
Claudin
Therapeutics
Drug Development
Kidney Fibrosis
Cancer
Date founded
2019
Funding rounds raised
Total raised
$105M
from 15 investors over 15 rounds
A
Alentis Therapeutics raised undisclosed on April 28, 2023
Investors: Innosuisse - Schweizerische Agentur für Innovationsförderung
A
Alentis Therapeutics raised $105M on April 13, 2023
Investors: Pureos Bioventures, Schroders Capital, Novo Holdings, RA Capital Management, L.P. and JEITO
A
Alentis Therapeutics raised $67M on June 15, 2021
Investors: Pureos Bioventures, Kinled Holding Ltd, BioMedPartners, High-Tech Gründerfonds, Morningside Venture Capital 晨兴资本 and JEITO
A
Alentis Therapeutics raised $12M on April 29, 2019
Investors: Pureos Bioventures, High-Tech Gründerfonds and BioMedPartners